Market Currents
Par Pharmaceutical (PRX +5%) agrees to acquire privately held Anchen Pharmaceuticals for $410M...
-
Wednesday, August 24, 2011, 12:27 PM ETPar Pharmaceutical (PRX +5%) agrees to acquire privately held Anchen Pharmaceuticals for $410M in cash, a move that will boost the generic drug maker's current pipeline and add to its R&D capabilities.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
